Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 7Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Other solid neoplasm 1

Conditions

Uveal Melanoma 2Retinoblastoma 1Retinal Diseases 1Melanoma 1Macular Degeneration 1Choroid Diseases 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 284Drug Therapy 244apatinib 242Bevacizumab 230camrelizumab 214Etoposide 200Irinotecan 177Doxorubicin 175Leucovorin 162Dexamethasone 160sintilimab 142pembrolizumab 140anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Ranibizumab × Clear all
NCT01899066 2014-05-13

Efficacy Study of Lucentis in the Treatment of Retinoblastoma

Sun Yat-sen University

Phase 2 Unknown
20 enrolled
Other solid neoplasm

Retinoblastoma

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown
220 enrolled
Dermatologic

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

NCT00540930 2007-10-08

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Shields, Shields and Associates

Phase 4 Unknown
400 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡